| Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma (NCT04097301) | AGC Biologics S.p.A. | 2019-08-27 |
| Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI) (NCT04047732) | Krystal Biotech, Inc. | 2019-08-27 |
| PK/PD Study of Gan & Lee Insulin Aspart Injection vs. US & EU NovoLog®/NovoRapid® in Healthy Males (NCT04237129) | Gan and Lee Pharmaceuticals, USA | 2019-08-27 |
| A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject (NCT04041544) | SinoMab BioScience Ltd | 2019-08-27 |
| ASTX727 and FT-2102 in Treating IDH1-Mutated Recurrent/Refractory Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT04013880) | Vanderbilt-Ingram Cancer Center | 2019-08-27 |
| Pirfenidone Capsule in Patients With Chronic Kidney Disease G2 and G3a Study on Safety and Pharmacokinetics (NCT04126538) | Beijing Continent Pharmaceutical Co, Ltd. | 2019-08-27 |
| A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin (NCT04070495) | Kyowa Kirin Co., Ltd. | 2019-08-27 |
| Study of VIR-2482 in Healthy Volunteers (NCT04033406) | Vir Biotechnology, Inc. | 2019-08-26 |
| Evaluating Relative Bioavailability of OC-01 (Varenicline) Nasal Spray as Compared to Orally Administered Varenicline (NCT04072146) | Oyster Point Pharma, Inc. | 2019-08-26 |
| A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Myeloma (NCT04036461) | Celgene | 2019-08-26 |
| Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ (NCT04061928) | Peking University | 2019-08-26 |
| Losartan + Sunitinib in Treatment of Osteosarcoma (NCT03900793) | University of Colorado, Denver | 2019-08-26 |
| Trial to Evaluate the Safety and Pharmacokinetics of HMPL-689 in Patients With Lymphomas (NCT03786926) | Hutchmed | 2019-08-26 |
| MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer (NCT04078269) | University Hospital, Ghent | 2019-08-26 |
| Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants (NCT03934541) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-26 |
| MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer (NCT04082182) | University Hospital, Ghent | 2019-08-26 |
| TAS-102 and Irinotecan in 2L+ Gastric and Gastroesophageal Adenocarcinoma (NCT04074343) | University of California, Irvine | 2019-08-26 |
| Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors (NCT04049617) | Gilead Sciences | 2019-08-26 |
| Effects of Psilocybin in Anorexia Nervosa (NCT04052568) | Johns Hopkins University | 2019-08-26 |
| Articaine Efficacy and Safety for Children Below Age of 4-years (NCT04061265) | Minia University | 2019-08-25 |
| CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia (NCT04004637) | PersonGen BioTherapeutics (Suzhou) Co., Ltd. | 2019-08-25 |
| Reconstruction of Partial Mastectomy Defects With Pectoralis Myo-glandular Local Flap. (NCT04091958) | Mansoura University | 2019-08-24 |
| A First-in-human Clinical Evaluation of SN132D in Patients With Breast and Pancreatic Cancer (NCT04080024) | Spago Nanomedical AB | 2019-08-23 |
| CPX-351+GO in Subjects 55 Years Old, or Older, With AML (NCT03878927) | Weill Medical College of Cornell University | 2019-08-23 |
| Fecal Microbiota Transplant for Primary CDI (NCT03795233) | Boston Medical Center | 2019-08-23 |
| Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis (NCT04041856) | Farabi Eye Hospital | 2019-08-23 |
| Efficacy and Safety Study of GX-I7 Plus Adjuvant Temozolomide Combination in Patients With Newly Diagnosed Glioblastoma (NCT04065087) | Genexine, Inc. | 2019-08-22 |
| A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets (NCT04065932) | Bristol-Myers Squibb | 2019-08-22 |
| Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants (NCT03961997) | Pfizer | 2019-08-22 |
| The Study of Oral Fluorescite to Confirm the Authenticity of Point of Care Urine Samples (NCT04071080) | UpTru Inc. | 2019-08-22 |
| Clinical Trial for Zebinix (Eslicarbazepine Acetate) in Healthy Korean and Caucasian Adult (NCT04095182) | Whanin Pharmaceutical Company | 2019-08-22 |
| Pharmacometabolomics of Andrographis Paniculata And Metformin In Healthy Volunteers Under Fasting Condition (NCT04161404) | University of Malaya | 2019-08-21 |
| Macular Pigment and Visual Performance in Glaucoma Patients (NCT03959592) | Felipe Medeiros, MD | 2019-08-21 |
| Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women (NCT04033237) | University of Vermont | 2019-08-21 |
| IRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma (NCT03381183) | H. Lee Moffitt Cancer Center and Research Institute | 2019-08-21 |
| Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure (NCT04784728) | Scilex Pharmaceuticals, Inc. | 2019-08-21 |
| A Study of LUT014 in Patients With Metastatic Colorectal Cancer With EGFR Inhibitor Induced Acneiform Lesions (NCT03876106) | Lutris Pharma Ltd. | 2019-08-21 |
| Phase 1, Open-label Study of the Absorption, Metabolism, and Excretion of [14C]-KW-6356 (NCT04147910) | Kyowa Kirin, Inc. | 2019-08-21 |
| ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) (NCT04044859) | USWM CT, LLC | 2019-08-20 |
| A Study of RTA 402 in Obese Adults (NCT04018339) | Kyowa Kirin Co., Ltd. | 2019-08-20 |
| A Study of C-CAR066 in Subjects With r/r B Cell Lymphoma Who Received CD19 CAR-T Therapy (NCT04036019) | Shanghai Tongji Hospital, Tongji University School of Medicine | 2019-08-20 |
| PSCA-CAR T Cells in Treating Patients With PSCA+ Metastatic Castration Resistant Prostate Cancer (NCT03873805) | City of Hope Medical Center | 2019-08-20 |
| Study in Beta-thalassaemia or Myelodysplastic Syndrome Patients to Investigate the Safety and Tolerability of SLN124 (NCT04176653) | Silence Therapeutics plc | 2019-08-20 |
| A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels (NCT04058834) | Novo Nordisk A/S | 2019-08-20 |
| Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer (NCT04067986) | Zhongshan Hospital Xiamen University | 2019-08-20 |
| A Study of Tirzepatide Administered by Two Different Devices in Healthy Participants (NCT04004988) | Eli Lilly and Company | 2019-08-19 |
| StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord (NCT03990597) | M.D. Anderson Cancer Center | 2019-08-19 |
| First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma (NCT04000282) | Sanofi | 2019-08-19 |
| Study of Lenalidomide, Venetoclax and Obinutuzumab in Patients With Treatment-Naïve Follicular Lymphoma (NCT03980171) | Peter MacCallum Cancer Centre, Australia | 2019-08-19 |
| Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation (NCT03963154) | Centre d'Etude des Cellules Souches | 2019-08-19 |
| Trial of Antibody Responses by Vitamin Supplementation (NCT03859687) | St. Jude Children's Research Hospital | 2019-08-19 |
| BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers (NCT04021043) | M.D. Anderson Cancer Center | 2019-08-19 |
| A Renal Impairment Study for PF-06651600 (NCT04037865) | Pfizer | 2019-08-19 |
| A Study to Evaluate the Effect of Saroglitazar Magnesium on the QTc Interval in Healthy Volunteers (NCT04045769) | Zydus Therapeutics Inc. | 2019-08-19 |
| A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis (NCT03952637) | National Human Genome Research Institute (NHGRI) | 2019-08-19 |
| Pharmacokinetic Study of Paracetamol. (NCT03953287) | Kolding Sygehus | 2019-08-18 |
| Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST) (NCT04138381) | Grupo Espanol de Investigacion en Sarcomas | 2019-08-16 |
| R2-MTX With Lenalidomide Maintenance in Newly-diagnosed PCNSL：a Multicenter Phase Ib/II Stuty (NCT04120350) | Peking Union Medical College Hospital | 2019-08-16 |
| Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT03874052) | Jennifer Saultz | 2019-08-16 |
| Cryotherapy With in Situ Immunotherapy in Melanoma Metastasis (NCT03949153) | University Hospital, Strasbourg, France | 2019-08-16 |
| Chimeric Antigen Receptor T Cells Targeting Glypican-3 (NCT03884751) | CARsgen Therapeutics Co., Ltd. | 2019-08-15 |
| A Study to Evaluate the Safety and Tolerability of Multiple Doses of Gerilimzumab in Rheumatoid Arthritis Patients (NCT04179513) | Genor Biopharma Co., Ltd. | 2019-08-15 |
| The Gut-Brain Study (NCT03426826) | Children's Hospital Los Angeles | 2019-08-15 |
| ATL001 in Patients With Metastatic or Recurrent Melanoma (NCT03997474) | Achilles Therapeutics UK Limited | 2019-08-15 |
| SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer (NCT04050085) | University of California, Davis | 2019-08-15 |
| Research Study to Investigate How a Study Medicine (NNC9204- 1177) Affects Blood Levels of Other Medicines in Healthy People (NCT04059367) | Novo Nordisk A/S | 2019-08-15 |
| Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced Osteosarcoma (NCT04044378) | Peking University People's Hospital | 2019-08-15 |
| A First-in-Humans Dose Finding Study for an Aryl Hydrocarbon Receptor Inhibitor (AhRi) in Patients With Advanced Cancer (NCT04069026) | Bayer | 2019-08-15 |
| A Study of CS3007 in Subjects With Gastrointestinal Stromal Tumor (NCT04254939) | CStone Pharmaceuticals | 2019-08-15 |
| Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors (NCT04047862) | BeiGene | 2019-08-15 |
| Efficacy of Erector Spinae Plane Block Versus Infraclavicular Subomohyoid Block in Shoulder Surgery (NCT04183244) | Ain Shams University | 2019-08-15 |
| Detection of Cannabis Impairment With an Eye Tracker (NCT03813602) | Centre for Addiction and Mental Health | 2019-08-15 |
| The Safety/Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-LDP) for Lumbar Discogenic Pain (NCT04104412) | Sclnow Biotechnology Co., Ltd. | 2019-08-15 |
| Nivolumab and Ipilimumab in Combination With Immunogenic Chemotherapy for Patients With Advanced NSCLC (NCT04043195) | Hatim Husain | 2019-08-14 |
| The Safety and Tolerability of SerpinPC in Healthy Men and in Men with Severe Blood Disorders (haemophilia a and B) (NCT04073498) | ApcinteX Ltd | 2019-08-14 |
| Phase II Study of FTD/TPI (Lonsurf) in Metastatic Breast Cancers With or Without Prior Exposure to Fluoropyrimidines (LONBRECA) (NCT04280536) | National University Hospital, Singapore | 2019-08-14 |
| A Study to Investigate the Effects of Cytochrome P450 1A2 Induction by Ritonavir on BMS-986165 Drug Levels and Effects in Healthy Participants (NCT04055506) | Bristol-Myers Squibb | 2019-08-14 |
| Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study) (NCT04064073) | Daewoong Pharmaceutical Co. LTD. | 2019-08-14 |
| TR1801-ADC in Patients With Tumors That Express c-Met (NCT03859752) | Open Innovation Partners, Inc. | 2019-08-14 |
| Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma (NCT03994913) | CARsgen Therapeutics Co., Ltd. | 2019-08-14 |
| Caffeine for Hypoxic-Ischemic Encephalopathy (NCT03913221) | University of North Carolina, Chapel Hill | 2019-08-14 |
| A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Englumafusp Alfa in Combination With Obinutuzumab and in Combination With Glofitamab Following a Pre-Treatment Dose of Obinutuzumab in Participants With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT04077723) | Hoffmann-La Roche | 2019-08-13 |
| A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Experimental Rabies Vaccine in Healthy Adults (NCT04062669) | GlaxoSmithKline | 2019-08-13 |
| GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma (NCT04060342) | GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 2019-08-13 |
| Safety and Immunotherapeutic Activity of an Anti-PD-1 Antibody (Cemiplimab) in Participants With HIV-1 on Suppressive cART (NCT03787095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2019-08-13 |
| Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants (NCT04044053) | Pfizer | 2019-08-13 |
| A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). (NCT04115345) | Prokidney | 2019-08-13 |
| Pharmacokinetics and Safety of RV521 Formulations (NCT04065698) | Pfizer | 2019-08-13 |
| Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma (NCT04047706) | Northwestern University | 2019-08-13 |
| Effect of Local Application of Platelet-rich Fibrin Scaffold Loaded With Simvastatin on Peri-implant Bone Changes (NCT05008068) | British University In Egypt | 2019-08-12 |
| Boost Brittle Bones Before Birth (NCT03706482) | Karolinska Institutet | 2019-08-12 |
| Gene Therapy for Achromatopsia (CNGA3) (NCT03758404) | MeiraGTx UK II Ltd | 2019-08-12 |
| The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients (NCT03951623) | Hutchison Medipharma Limited | 2019-08-12 |
| A Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Participants With Multiple Sclerosis (NCT03972306) | Hoffmann-La Roche | 2019-08-12 |
| Safety and Efficacy of SCM-AGH in Patients With Moderate to Severe Acute Pancreatitis (NCT04189419) | SCM Lifescience Co., LTD. | 2019-08-12 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB094 in Adults With Parkinson's Disease (NCT03976349) | Ionis Pharmaceuticals, Inc. | 2019-08-12 |
| Xanthohumol Metabolism and Signature (NCT03735420) | National University of Natural Medicine | 2019-08-12 |
| A Research Study of How Semaglutide Works in People With Disease Affecting the Heart and/or Blood Vessels and Type 2 Diabetes (NCT04032197) | Novo Nordisk A/S | 2019-08-12 |
| Assess the Safety, Tolerability Oral PU-H71 in Subjects Taking Ruxolitinib (NCT03935555) | Samus Therapeutics, Inc. | 2019-08-12 |
| A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors (NCT03972657) | Regeneron Pharmaceuticals | 2019-08-12 |